Searching across hundreds of databases

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Effects of antifibrinolytics on systemic and cerebral inflammation after traumatic brain injury.

TE Wallen | KE Singer | MR Baucom | LG England | RM Schuster | TA Pritts | MD Goodman
The journal of trauma and acute care surgery | 2022 Jul 01

Administration of antifibrinolytic medications, including tranexamic acid (TXA), may reduce head injury-related mortality. The effect of these medications on post-traumatic brain injury (TBI) inflammatory response is unknown. The goal of this study was to investigate the role of available antifibrinolytic medications on both systemic and cerebral inflammation after TBI.

Pubmed ID: 35319541

TBI Model

  • Weight-drop model
  • Animal Information

  • Species: mouse
  • Strain: C57BL/6
  • Age (weeks): 9 - 10
  • Weight (grams): No weight reported
  • Assessments

    Hippocampal histology, neuron-specific enolase

    TBI model parameters

  • Impact Depth (mm): No information available
  • Impact Duration (ms): No information available
  • Impact Velocity (m/s): No information available
  • Impactor Tip: No information available
  • Device Name

    No information available

    Associated Datasets

    No information available

    Associated Protocols

    No information available